Profile
Anna Gralinska is currently the Head of Corporate Communications at Bio-Rad Laboratories, Inc. She previously worked as the Director of Investor Relations at Mallinckrodt Hospital Products, Inc.
Anna Gralinska active positions
| Companies | Position | Start |
|---|---|---|
| BIO-RAD LABORATORIES, INC. | Public Communications Contact | 2022-03-31 |
Former positions of Anna Gralinska
| Companies | Position | End |
|---|---|---|
| CADENCE PHARMACEUTICALS, INC. | Investor Relations Contact | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| BIO-RAD LABORATORIES, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Mallinckrodt Hospital Products, Inc.
 Mallinckrodt Hospital Products, Inc. Pharmaceuticals: MajorHealth Technology Mallinckrodt Hospital Products, Inc. operates as a biopharmaceutical company, which develops and commercializes proprietary product candidates used in the hospital setting. The firm offers OFIRMEV (acetaminophen injection), a proprietary intravenous formulation of acetaminophen for the management of mild to moderate pain, the management of moderate to severe pain with adjunctive opioid analgesics and the reduction of fever. The company was founded by Theodore R. Schroeder, David A. Socks, and Cam L. Garner on May 26, 2004 and is headquartered in Hazelwood, MO. | Health Technology |
- Stock Market
- Insiders
- Anna Gralinska
